Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis — BALANCE  

Perennial Allergic Rhinitis (PAR) Clinical Trial

Official title: Investigation of the Real World Effectiveness of Beclomethasone Dipropionate (BDP) Nasal Aerosol in Perennial Allergic Rhinitis (PAR) Patients

Status Completed

Clinical Trial Summary

This study will be a prospective observational study of "real world" BDP nasal aerosol users with PAR, with or without seasonal allergic rhinitis (SAR). Subjects will respond to monthly online surveys regarding rhinitis control, concomitant medical conditions, concomitant (non-AR) medications, current AR therapy, and adverse events.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Perennial Allergic Rhinitis (PAR)
• Rhinitis
• Rhinitis, Allergic, Perennial

• NCT number: NCT01632540
• Study type: Observational [Patient Registry]
• Source: Teva Pharmaceutical Industries
• Status: Completed
• Phase: N/A
• Start date: July 2012
• Completion date: February 2014